HCA Healthcare, Inc. vs Johnson & Johnson
HCA vs JNJ — side-by-side comparison from reported financials. HCA leads 4, JNJ leads 7 of 11 comparable metrics.
HCA Healthcare, Inc.
HCA · Healthcare
$445.04+0.01%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | HCA | JNJ |
|---|---|---|
| Price | $445.04 | $261.79 |
| Market cap | $96.3B | $631B |
| Revenue (TTM) | $78.0B | $97.9B |
| Revenue growth | +7.9% | +5.6% |
| Net margin | 8.8% | 21.5% |
| Free cash flow | $6.00B | $22.2B |
| Net cash (debt) | ($45.5B) | ($27.8B) |
| 1-year price return | +6.2% | +37.0% |
| P/E | 14.3 | 29.9 |
| P/E vs own history (cheap-side %) | 44% | 16% |
| Dividend yield | 0.70% | 2.00% |
| Return on equity | 696% | 26% |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 320,000 | 140,800 |
Full résumé-style profiles: HCA CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.